Suppr超能文献

在接受根治性切除的IV期结直肠癌患者中,阳性淋巴结的对数比值作为预后指标。

Log odds of positive lymph nodes as a prognostic indicator in stage IV colorectal cancer patients undergoing curative resection.

作者信息

Ozawa Tsuyoshi, Ishihara Soichiro, Sunami Eiji, Kitayama Joji, Watanabe Toshiaki

机构信息

Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

出版信息

J Surg Oncol. 2015 Mar 15;111(4):465-71. doi: 10.1002/jso.23855. Epub 2015 Feb 17.

Abstract

BACKGROUND

Recent studies have proposed the use of log odds of positive lymph nodes (LODDS) as a prognostic indicator in colorectal cancer (CRC) patients without distant synchronous metastasis. In the present study, we aimed to evaluate the prognostic impact of the LODDS in Stage IV CRC patients who have undergone curative resection.

METHODS

We performed a retrospective review of 117 Stage IV CRC patients who underwent curative resection at our institute from 1998 to 2011. Patients were categorized into 3 groups (LODDS1-3) according to the ratio of their LODDS. The relationship between the LODDS and disease-free survival (DFS) and overall survival (OS) rates were assessed.

RESULTS

DFS was not significantly different between patients in each LODDS group. The association between the LODDS classification and OS was statistically significant (P = 0.021). Multivariate analysis indicated that LODDS classification was an independent prognostic factor for OS, with a hazard ratio of 2.95 for LODDS2 (95% confidence interval [CI]: 1.18-8.35; P = 0.021), and 2.98 for LODDS3 (95% CI: 1.20-8.37; P = 0.017).

CONCLUSIONS

The LODDS is a good prognostic indicator in Stage IV CRC patients who have undergone curative resection.

摘要

背景

近期研究提出将阳性淋巴结对数比(LODDS)作为无远处同步转移的结直肠癌(CRC)患者的预后指标。在本研究中,我们旨在评估LODDS对接受根治性切除的IV期CRC患者的预后影响。

方法

我们对1998年至2011年在我院接受根治性切除的117例IV期CRC患者进行了回顾性研究。根据患者的LODDS比值将其分为3组(LODDS1 - 3)。评估LODDS与无病生存期(DFS)和总生存期(OS)率之间的关系。

结果

各LODDS组患者的DFS无显著差异。LODDS分类与OS之间的关联具有统计学意义(P = 0.021)。多变量分析表明,LODDS分类是OS的独立预后因素,LODDS2的风险比为2.95(95%置信区间[CI]:1.18 - 8.35;P = 0.021),LODDS3的风险比为2.98(95%CI:1.20 - 8.37;P = 0.017)。

结论

LODDS是接受根治性切除的IV期CRC患者的良好预后指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验